A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and follow-on Formula for Healthy Term Infants.

Inclusion Criteria: * Healthy, singleton, term born infants (gestational age ≥ 37 weeks + 0 days and ≤ 41 weeks + 6 days). * Infants aged ≤ 14 days at enrolment. * Weight at birth within 10th to 90th percentile per gestational age and sex, according to Intergrowth Standards * For formula feeding groups: Infants fully formula fed at the time of enrolment. * For breastfed reference group: Infants exclusively breastfed at the time of enrolment and parent(s) intend to exclusively breastfeed the infant at least until 16 weeks after Visit 1. * Written informed consent (IC) from parent(s) and/or legally acceptable representative(s) aged ≥18 years at enrolment. Exclusion Criteria: * . Infants who require a special diet other than IF with intact cow's milk protein. * Infants known or suspected to have cow's milk, fish, and/or soy allergy and/or lactose intolerance. * Infants with current or previous illnesses/conditions and/or known or suspected congenital diseases or malformations which could interfere with the study outcomes, as per investigator's clinical judgement. * Infants whose mother is known to suffer from an illness or condition which could interfere with the study outcomes, as per investigator's clinical judgement. * Infants with previous, current, or intended participation in any concomitant clinical study involving investigational or marketed products. * Investigator's uncertainty about the willingness or ability of parents or legally acceptable representative(s) to co…